Emerging studies suggest Retatru tide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to provide a promising step forward for obesity treatment. https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide